81 FR 21577 - Donor Screening Recommendations To Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products; Guidance for Industry; Availability; Correction

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 81, Issue 70 (April 12, 2016)

The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of Monday, March 7, 2016 (81 FR 11808). The document announced a guidance for industry entitled ``Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products.'' The document was published with an incorrect docket number in the ADDRESSES section. This document corrects that error.

[Federal Register Volume 81, Number 70 (Tuesday, April 12, 2016)]
[Notices]
[Page 21577]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-08330]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2016-D-0768]


Donor Screening Recommendations To Reduce the Risk of 
Transmission of Zika Virus by Human Cells, Tissues, and Cellular and 
Tissue-Based Products; Guidance for Industry; Availability; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of Monday, March 7, 2016 (81 FR 
11808). The document announced a guidance for industry entitled ``Donor 
Screening Recommendations to Reduce the Risk of Transmission of Zika 
Virus by Human Cells, Tissues, and Cellular and Tissue-Based 
Products.'' The document was published with an incorrect docket number 
in the ADDRESSES section. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy, 
Planning, Legislation, and Analysis, Food and Drug Administration, 
10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993-
0002, 301-796-9115.

SUPPLEMENTARY INFORMATION: In FR Doc. 2016-04893, appearing on page 
11808 in the Federal Register of Monday, March 7, 2016, the following 
correction is made:
    1. On page 11808, in the third column, the docket number is 
corrected to read ``FDA-2016-D-0768''.

    Dated: April 6, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-08330 Filed 4-11-16; 8:45 am]
 BILLING CODE 4164-01-P